WO2000068249B1 - Nouvelles proteines de modulateur de proteine g (gpm), molecules d'acide nucleique, et leurs utilisations - Google Patents

Nouvelles proteines de modulateur de proteine g (gpm), molecules d'acide nucleique, et leurs utilisations

Info

Publication number
WO2000068249B1
WO2000068249B1 PCT/US2000/012502 US0012502W WO0068249B1 WO 2000068249 B1 WO2000068249 B1 WO 2000068249B1 US 0012502 W US0012502 W US 0012502W WO 0068249 B1 WO0068249 B1 WO 0068249B1
Authority
WO
WIPO (PCT)
Prior art keywords
gpm
protein
cell
seq
agent
Prior art date
Application number
PCT/US2000/012502
Other languages
English (en)
Other versions
WO2000068249A3 (fr
WO2000068249A2 (fr
Inventor
Stephen M Lanier
Aya Takesono
Mary Cismowski
Emir Duzic
Original Assignee
Musc Found For Res Dev
Osi Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Musc Found For Res Dev, Osi Pharm Inc filed Critical Musc Found For Res Dev
Priority to EP00930459A priority Critical patent/EP1179006A4/fr
Priority to AU48276/00A priority patent/AU4827600A/en
Publication of WO2000068249A2 publication Critical patent/WO2000068249A2/fr
Publication of WO2000068249A3 publication Critical patent/WO2000068249A3/fr
Publication of WO2000068249B1 publication Critical patent/WO2000068249B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

L'invention concerne de nouvelles protéines polypeptidiques de modulateur de protéine G (GPM), et des molécules d'acide nucléique, qui stimulent l'activité de la protéine G indépendamment d'un récepteur. En outre, cette invention permet de fournir des protéines de fusion GPM isolées, des peptides antigènes, et des anticorps anti-GPM aux protéines GPM isolées pleine longueur. Elle fournit également des molécules GPM d'acide nucléique, des vecteurs d'expression de recombinaison contenant ladite molécule d'acide nucléique, des cellules hôtes dans lesquelles les vecteurs d'expression ont été introduits, et des animaux transgéniques non humains dans lesquels le gène GPM a été introduit ou interrompu. Elle concerne enfin un diagnostic, un criblage et des techniques utilisant lesdites compositions.
PCT/US2000/012502 1999-05-07 2000-05-05 Nouvelles proteines de modulateur de proteine g (gpm), molecules d'acide nucleique, et leurs utilisations WO2000068249A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP00930459A EP1179006A4 (fr) 1999-05-07 2000-05-05 Nouvelles proteines de modulateur de proteine g (gpm), molecules d'acide nucleique, et leurs utilisations
AU48276/00A AU4827600A (en) 1999-05-07 2000-05-05 Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30710599A 1999-05-07 1999-05-07
US09/307,105 1999-05-07

Publications (3)

Publication Number Publication Date
WO2000068249A2 WO2000068249A2 (fr) 2000-11-16
WO2000068249A3 WO2000068249A3 (fr) 2001-10-25
WO2000068249B1 true WO2000068249B1 (fr) 2002-01-17

Family

ID=23188261

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/012502 WO2000068249A2 (fr) 1999-05-07 2000-05-05 Nouvelles proteines de modulateur de proteine g (gpm), molecules d'acide nucleique, et leurs utilisations

Country Status (3)

Country Link
EP (1) EP1179006A4 (fr)
AU (1) AU4827600A (fr)
WO (1) WO2000068249A2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001519157A (ja) * 1997-10-07 2001-10-23 ケイダス ファーマスーティカル コーポレイション 改変g蛋白質を発現する酵母細胞及びそれらの利用方法
WO1999058670A1 (fr) * 1998-05-08 1999-11-18 Cadus Pharmaceutical Corporation Molecules d'acides nucleiques et proteines ags, et utilisations correspondantes
AUPQ223999A0 (en) * 1999-08-16 1999-09-09 University Of Sydney, The Intracellular feedback controls in the diagnosis and treatment of human disease

Also Published As

Publication number Publication date
AU4827600A (en) 2000-11-21
EP1179006A2 (fr) 2002-02-13
WO2000068249A3 (fr) 2001-10-25
EP1179006A4 (fr) 2003-03-19
WO2000068249A2 (fr) 2000-11-16

Similar Documents

Publication Publication Date Title
CN112048005B (zh) 新型冠状病毒s蛋白片段多倍体及其制备方法、检测试剂盒、疫苗及药物
Ringwald et al. The structure of cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca2+‐dependent cell adhesion.
CA2413857A1 (fr) Molecules pd-l2: nouveaux ligands pour pd-1 et leurs utilisations
US9005911B2 (en) Methods for identifying inhibitors of botulinum neurotoxins
AU743490B2 (en) NTN-2 member of TNF ligand family
KR100210183B1 (ko) 세포-유리된 수용체 결합 검정물, 이의 제조방법 및 용도
Carson Receptor for the group B coxsackieviruses and adenoviruses: CAR
CA2353086A1 (fr) Pgc-1: un coactivateur du recepteur ppar.gamma. des tissus adipeux bruns
CA2383424A1 (fr) Nouvelles molecules b7-4 et leurs utilisations
CA2290944A1 (fr) Pgc-1, un nouveau coactivateur ppar.gamma. de graisses brunes
SZAKÁCS et al. Role of glycine-534 and glycine-1179 of human multidrug resistance protein (MDR1) in drug-mediated control of ATP hydrolysis
EP1019502A2 (fr) Nouveau recepteur orphelin
JP4604184B2 (ja) 新規糖鎖認識蛋白質及びその遺伝子
CN113599512A (zh) 免疫组合物
Radulescu et al. Binding of the LXCXE insulin motif to a hexapeptide derived from retinoblastoma protein
Almenoff et al. Induction of heat-stable enterotoxin receptor activity by a human Alu repeat
US6420120B1 (en) Use of a polypeptide as cell receptor for adenoviruses
WO2000068249B1 (fr) Nouvelles proteines de modulateur de proteine g (gpm), molecules d'acide nucleique, et leurs utilisations
US20160333386A1 (en) Use of peptidylglycine alpha-amidating monooxigenase (pam) for c-terminal amidation
CN106496330B (zh) 一种VDR-His融合蛋白及其DNA序列、表达方法和应用
US20020127624A1 (en) INGAP displacement assays
JP4423394B2 (ja) 新規糖鎖認識蛋白質及びその遺伝子
WO2004007551A1 (fr) Variante d'epissage du recepteur cannabinoide (cb1b)
US5196526A (en) CDNA clone for T-cell suppressor inducer factor
KR940007181A (ko) 성장 호르몬 방출 호르몬 수용체의 분리, 특성화 및 단백질 서열화 및 성장 호르몬 방출 호르몬 수용체를 암호하는 유전자의 클로닝

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2000930459

Country of ref document: EP

AK Designated states

Kind code of ref document: B1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

B Later publication of amended claims
WWP Wipo information: published in national office

Ref document number: 2000930459

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000930459

Country of ref document: EP